Cetirizine Placebo

DRUG2 trials

Sponsors

GlaxoSmithKline, Emory University

Conditions

COVID-19Rhinitis, Allergic, Perennial and Seasonal

Phase 3

Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

TerminatedNCT05946551

Emory UniversityCOVID-19

Start: 2024-03-08End: 2024-06-24Updated: 2025-07-17

Phase 4

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

CompletedNCT01916226

GlaxoSmithKlineRhinitis, Allergic, Perennial and Seasonal

Start: 2013-08-01End: 2013-10-17Updated: 2018-06-20

Related Papers

Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia

BMJ Open2024-05-0120 citations

A comparison of fluticasone propionate nasal spray and cetirizine in ragweed fall seasonal allergic rhinitis

Allergy and Asthma Proceedings2015-06-2312 citations